Jae-Ho Chung1, Ki-Jae Kim1, Seung Pil Jung2, Seung-Ha Park1, Eul-Sik Yoon1. 1. Department of Plastic and Reconstructive Surgery, Korea University Hospital, Seoul, Republic of Korea. 2. Division of Breast and Endocrine Surgery, Korea University Hospital, Seoul, Republic of Korea.
Abstract
BACKGROUND: Fat grafting is now a common procedure for breast reconstruction. Many clinical studies have reported its aesthetic efficacy and oncological safety, but some experimental studies raise about the recurrence risk because of its regenerating property. This study aims to investigate the possibility of cancer recurrence associated with fat grafting. METHODS: In this retrospective cohort study, we analyzed a total of 339 patients who had undergone immediate reconstructive surgery after nipple-sparing mastectomy (NSM) or skin-sparing mastectomy (SSM) in our institution between February 28, 2009 and March 23, 2019. Patients who had undergone breast conserving surgery, radical mastectomy, or delayed reconstruction were excluded. We used univariate and multivariate Cox proportional hazards regression models to evaluate the association between fat grafting and cancer recurrence. RESULTS: Among the 339 patients during a median follow-up of 52 months, 27 patients (8.0%) were confirmed to have recurrent cancer. Of 67 patients who had undergone fat grafting, 10 patients were confirmed to have cancer recurrence. In multivariate analyses, fat grafting [hazard ratio (HR), 2.52; 95% CI, 1.005-6.317; P=0.0488] was independently associated with cancer recurrence. CONCLUSIONS: In population of breast cancer patient who underwent immediate reconstruction in our institution, fat grafting showed significant higher risk of cancer recurrence. Although these results are at odds with many existing studies, it suggests that more careful follow-up may be necessary for patients who had undergone fat grafting after reconstructive surgery. 2021 Gland Surgery. All rights reserved.
BACKGROUND: Fat grafting is now a common procedure for breast reconstruction. Many clinical studies have reported its aesthetic efficacy and oncological safety, but some experimental studies raise about the recurrence risk because of its regenerating property. This study aims to investigate the possibility of cancer recurrence associated with fat grafting. METHODS: In this retrospective cohort study, we analyzed a total of 339 patients who had undergone immediate reconstructive surgery after nipple-sparing mastectomy (NSM) or skin-sparing mastectomy (SSM) in our institution between February 28, 2009 and March 23, 2019. Patients who had undergone breast conserving surgery, radical mastectomy, or delayed reconstruction were excluded. We used univariate and multivariate Cox proportional hazards regression models to evaluate the association between fat grafting and cancer recurrence. RESULTS: Among the 339 patients during a median follow-up of 52 months, 27 patients (8.0%) were confirmed to have recurrent cancer. Of 67 patients who had undergone fat grafting, 10 patients were confirmed to have cancer recurrence. In multivariate analyses, fat grafting [hazard ratio (HR), 2.52; 95% CI, 1.005-6.317; P=0.0488] was independently associated with cancer recurrence. CONCLUSIONS: In population of breast cancer patient who underwent immediate reconstruction in our institution, fat grafting showed significant higher risk of cancer recurrence. Although these results are at odds with many existing studies, it suggests that more careful follow-up may be necessary for patients who had undergone fat grafting after reconstructive surgery. 2021 Gland Surgery. All rights reserved.
Entities:
Keywords:
Fat graft; breast cancer; breast reconstruction; cancer recurrence
Authors: R Pérez-Cano; J J Vranckx; J M Lasso; C Calabrese; B Merck; A M Milstein; E Sassoon; E Delay; E M Weiler-Mithoff Journal: Eur J Surg Oncol Date: 2012-03-15 Impact factor: 4.424
Authors: Alessandra Bielli; Maria G Scioli; Pietro Gentile; Valerio Cervelli; Augusto Orlandi Journal: Adv Clin Exp Med Date: 2015 May-Jun Impact factor: 1.727
Authors: Sławomir Mazur; Aleksandra Zołocińska; Katarzyna Siennicka; Karolina Janik-Kosacka; Anna Chrapusta; Zygmunt Pojda Journal: Adv Clin Exp Med Date: 2018-08 Impact factor: 1.727
Authors: C Calabrese; A Kothari; S Badylak; G Di Taranto; M Marcasciano; S Sordi; L Barellini; F Lo Torto; M Tarallo; I Gaggelli; G D'Ermo; A Fausto; D Casella; D Ribuffo Journal: Eur Rev Med Pharmacol Sci Date: 2018-08 Impact factor: 3.507
Authors: Fabian L Muehlberg; Yao-Hua Song; Alexander Krohn; Severin P Pinilla; Lilly H Droll; Xiaohong Leng; Max Seidensticker; Jens Ricke; Andrew M Altman; Eswaran Devarajan; Weili Liu; Ralph B Arlinghaus; Eckhard U Alt Journal: Carcinogenesis Date: 2009-01-30 Impact factor: 4.944
Authors: Bruce A Bunnell; Elizabeth C Martin; Margarite D Matossian; Courtney K Brock; Khoa Nguyen; Bridgette Collins-Burow; Matthew E Burow Journal: Cancer Metastasis Rev Date: 2022-08-24 Impact factor: 9.237